Touhami Vision Center

Des scientifiques de l'Université de Newcastle ont imprimé en 3D les premières cornées humaines au monde.

En créant une encre bio spéciale utilisant des cellules souches mélangées à de l'alginate et du collagène, ils ont pu imprimer la cornée à l'aide d'une simple bio-imprimante 3D à faible coût.

Après de nouveaux tests, nous espérons que cette nouvelle technique pourra être utilisée pour lutter contre la pénurie mondiale de cornées chez les 15 millions de personnes nécessitant une greffe.

Newcastle University 3D Print World's First Human Corneas Scientists at Newcastle University have 3D printed the world's first human corneas. By creating a special bio-ink using stem cells mixed together with algina...

Des chercheurs d'Oxford ont mené la première opération de thérapie génique au monde pour s'attaquer à la cause fondamentale de la dégénérescence maculaire liée à l'âge (DMLA).

The first Prima bionic vision system has been successfully implanted and activated in a human subject, according to a press release from Pixium Vision.

The system, a miniature wireless photovoltaic subretinal implant, elicited visual perception in a patient with severe vision loss due to atrophic dry age-related macular degeneration.

In a new study published in the Nature Journal "Scientific Reports", neuroscientists at the University of Glasgow have used functional MRI to show how the human brain can predict what our eyes will see next.We move our eyes approximately 4 times per second, meaning our brains have to process new visual information every 250 milliseconds. Nevertheless, the world appears stable because our brains think ahead.

Stop smoking is the best investment you can make in your long-term eye health.At any age, smoking increases your risks for developing cataracts, central vision loss from age-related macular degeneration (AMD) or vascular accidents that may lead to blindness.

RxSight Inc announced that the FDA has approved the RxSight™ Light Adjustable Lens (RxLAL™) and the Light Delivery Device.Using a special lens material designed by a Nobel Prize winning scientist,RxSight Inc has developed the world’s first post-operative adjustable intraocular lens that allows office-based optimization of vision after lens implantation and healing.

Good news for patients with Keratoconus.The FDA granted orphan drug designation to IVMED-80, an eye drop used for cross-linking the cornea to treat Keratoconus. IVeena Delivery System will begin clinical development in 2018.